Transdermal scopolamine delivery system (TRANSDERM-V) and acute angle-closure glaucoma.
A 58-year-old woman developed unilateral acute angle-closure glaucoma four days after the application of a patch of transdermal scopolamine delivery system (TRANSDERM-V).
D000208:Acute Disease; D003692:Delayed-Action Preparations; D048909:Diabetes Complications; D005260:Female; D005901:Glaucoma / Q000139:chemically induced* / Q000628:therapy; D006801:Humans; D008875:Middle Aged; D009041:Motion Sickness / Q000150:complications / Q000188:drug therapy*; D012601:Scopolamine / Q000009:adverse effects* / Q000627:therapeutic use
D003692:Delayed-Action Preparations; D012601:Scopolamine